Rigorous science is at the core of Incyte. We are committed to improving the lives of patients, making a difference in healthcare and building sustainable value for our stakeholders through scientific discovery.
Headquartered in Wilmington, Delaware, Incyte has operations in the U.S., Europe and Japan. Today, we are a company of over 1,400 employees, including 600 world-class scientists who are leading the field of biopharmaceutical research.
Drug Discovery & Development
Incyte’s unique expertise in medicinal chemistry and biology have enabled us to create a diversified pipeline of clinical candidates, the majority of which were discovered by Incyte scientists. We are advancing a growing portfolio of medicines in hematology & oncology and inflammation & autoimmunity. The breadth of our portfolio and its balance between early- and later-stage candidates is unique for a company of our size.
Commitment to Patients
At Incyte, we are committed to positively impacting the lives of patients with serious diseases. We believe in the power of research to advance scientific innovation and improve patient health. Our clinical research is held to the highest standards of scientific and ethical rigor, and we strive to implement initiatives to remove barriers to access our medicines.
Culture and Employees
Since the beginning, Incyte has embraced and embodied an entrepreneurial spirit. Our core strength lies in the collective experience and passion of our team.
Incyte has grown more than two-fold over the last two years as we seek the best talent from both academia and industry to support our growing portfolio. Our size and approach enable every team member to contribute to the success of the company and to deliver on our mission of improving the lives of patients. Visit our Careers page to explore current opportunities and learn more about working at Incyte.